Zacks Research Has Bullish Forecast for THC FY2026 Earnings

Tenet Healthcare Corporation (NYSE:THC) – Equities research analysts at Zacks Research raised their FY2026 earnings per share estimates for Tenet Healthcare in a report released on Thursday, August 13th. Zacks Research analyst Team now anticipates that the company will earn $20.32 per share for the year, up from their prior estimate of $17.52. Zacks Research has a “Strong-Buy” rating on the stock. The consensus estimate for Tenet Healthcare’s current full-year earnings is $20.97 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q4 2026 earnings at $5.04 EPS, Q2 2027 earnings at $4.66 EPS, Q3 2027 earnings at $4.50 EPS, Q4 2027 earnings at $5.13 EPS, FY2027 earnings at $18.91 EPS, Q2 2028 earnings at $5.35 EPS and FY2028 earnings at $20.09 EPS.

THC has been the topic of several other reports. Robert W. Baird increased their target price on shares of Tenet Healthcare from $210.00 to $280.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 28th. Morgan Stanley upped their price target on Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research note on Monday, July 27th. Wall Street Zen downgraded Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Raymond James Financial reaffirmed an “outperform” rating and set a $285.00 target price on shares of Tenet Healthcare in a research report on Friday. Finally, Mizuho set a $290.00 price target on Tenet Healthcare in a research report on Monday, August 10th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Tenet Healthcare has an average rating of “Moderate Buy” and a consensus target price of $273.00.

Tenet Healthcare Stock Down 1.0%

THC stock opened at $265.18 on Monday. The firm has a market cap of $21.35 billion, a PE ratio of 10.23, a PEG ratio of 1.02 and a beta of 1.23. Tenet Healthcare has a 1 year low of $157.58 and a 1 year high of $270.57. The company has a fifty day simple moving average of $212.24 and a 200 day simple moving average of $204.56. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The firm had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. During the same period in the previous year, the company earned $4.02 earnings per share. The company’s revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS.

Insider Buying and Selling

In other news, EVP Lisa Y. Foo sold 10,000 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $258.03, for a total transaction of $2,580,300.00. Following the sale, the executive vice president owned 32,053 shares of the company’s stock, valued at approximately $8,270,635.59. This trade represents a 23.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Christopher S. Lynch sold 3,837 shares of the business’s stock in a transaction that occurred on Monday, July 27th. The shares were sold at an average price of $243.44, for a total value of $934,079.28. Following the sale, the director owned 9,568 shares in the company, valued at approximately $2,329,233.92. This represents a 28.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 41,375 shares of company stock worth $9,793,347. 0.97% of the stock is currently owned by corporate insiders.

Institutional Trading of Tenet Healthcare

Several institutional investors have recently made changes to their positions in the business. Norges Bank acquired a new position in Tenet Healthcare in the fourth quarter worth about $248,494,000. Wellington Management Group LLP grew its stake in shares of Tenet Healthcare by 1,114.2% in the 4th quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock valued at $225,706,000 after purchasing an additional 1,042,260 shares during the period. Manning & Napier Advisors LLC acquired a new position in shares of Tenet Healthcare in the 2nd quarter worth approximately $168,761,000. Boston Partners lifted its position in shares of Tenet Healthcare by 38.8% during the 3rd quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after buying an additional 880,413 shares during the period. Finally, AQR Capital Management LLC boosted its stake in Tenet Healthcare by 62.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after buying an additional 720,160 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.